Recombinant human B natriuretic peptide(iangsu Jingze biological)

重组人B型利钠肽（江苏景泽生物）

Report date: 2024/11/29 15:39:38

Base Information

Drug NameRecombinant human B natriuretic peptide(iangsu Jingze biological)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcutely decompensated congestive heart failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Jingze Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Jingze Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAcutely decompensated congestive heart failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A